azathioprine has been researched along with Familial Spastic Paraparesis, Htlv-1-Associated in 2 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakagawa, M | 1 |
Nakahara, K | 1 |
Maruyama, Y | 1 |
Kawabata, M | 1 |
Higuchi, I | 1 |
Kubota, H | 1 |
Izumo, S | 1 |
Arimura, K | 1 |
Osame, M | 2 |
1 trial available for azathioprine and Familial Spastic Paraparesis, Htlv-1-Associated
Article | Year |
---|---|
Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory A | 1996 |
1 other study available for azathioprine and Familial Spastic Paraparesis, Htlv-1-Associated
Article | Year |
---|---|
[HTLV-I-associated myelopathy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Child; Female; HTLV-I Antibodies; Humans; | 1992 |